Welcome to cooperate, TCM fills the gap and cure osteonecrosis and other diseases
Chairman of Beijing Kuangda Pharmaceutical Factory attended the 5th Belt and Road Forum for the Development of Traditional Chinese Medicine and delivered a keynote speech.
In September 2nd, the 5th Belt and Road Forum for the development of Traditional Chinese Medicine was successfully held in Beijing National Convention Center. The form aims to comprehensively improve the quality and level of Chinese medicine’s participation in building the Belt and Road. Give full play to the unique advantages of traditional Chinese medicine in the construction of healthy China, to help build the human health community. The forum is co-sponsored by the China Council for the Promotion of International Trade, the National Administration of Traditional Chinese Medicine, the Chinese People’s Association for Friendship with Foreign Countries and the Beijing Municipal People’s Government. More than 200 people attended the meeting, including officials from relevant Chinese and foreign government departments, representatives of the World Health Organization, academicians of Engineering, envoys to China, and representatives of enterprises. Beijing Kuangda Pharmaceutical Factory, as an excellent enterprise in the field of traditional Chinese medicine and health, was invited to attend the meeting. Wang Lulin, chairman of Beijing Kuangda Pharmaceutical Factory, delivered a keynote speech.
According to the combination of TCM thinking and modern science and technology, expert Wang Lulin’s research team studies the use of traditional Chinese medicine to promote the regeneration and repair of human cells. According to the principle of dredging meridians and collaterals, promoting blood circulation and removing blood stasis, and generate bone production, and by selecting Chinese herbal medicines such as Angelica sinensis, pseudo-ginseng, Pearl, earthworm and Cordyceps sinensis, Wang Lulin’s research team has developed the product with approved number by SFDA (State Food and Drug Administration)——Chinese Bone-strengthening pill (also called Jiangusheng Wan), a traditional Chinese medicine that can promote the regeneration and repair of bone and cartilage cells, and activate the regeneration and repair function of the human body, which has been experimentally and long-term clinically confirmed: it can inhibit and reverse the necrosis of bone cells and cartilage cells, repair the femoral head, and treat bone and cartilage diseases. Not only the clinical symptoms of the patients are improved, but also the repair is shown on the X-ray, Magnetic Resonance Imaging and so on, which has solved the problem of drug-free repair of osteonecrosis and other osteoarthropathy.
This achievement has been recognized by international and domestic academia, and many papers written by experts from Peking Union Medical College Hospital etc. have been published in internationally renowned academic journals:
1.Bone-strengthening pill (BSP) promotes bone cell and chondrocyte repair, and the clinical and experimental study of BSP in the treatment of osteonecrosis of the femoral head.Oncotarget. 2017; 8:97079-97089.ncotarge17,
2.Bone-strengthening supplement (BSP) promotes bone and cartilage repair, for the treatment of Osteonecrosis of Femoral Head: an MRI-based study.Am J Transl Res 2019;11(12):7449-7455
3.Experimental research into using bone-strengthening pill to treat ischemic necrosis of femoral head. J Tradit Chin Med 2012 June 15; 32(2): 249-255
4. Google News -Search：Chinese Bone-strengthening pill (Jiangusheng Wan) promotes bone cell and chondrocyte repair.“So far there are no effective methods or drugs to promote the repair of bone and chondrocyte disease in the world. This study has solved such problem and has made a breakthrough in the treatment of osteonecrosis, as well as bone and cartilage diseases, and fill a medical gap in the treatment of major, multiple and refractory diseases in the world. The study was published in a renowned international journal, entitled Bone strengthening pill (BSP) promotes bone cell and chondrocyte repair, and the clinical and experimental study of BSP in the treatment of osteonecrosis of the femoral head.”
As for the significance of successful development of Jiangusheng Pill, Wang Lulin thinks that the successful development of Jiangusheng Pill has proved that the compound preparation of traditional Chinese medicine can quantitatively and selectively cure major human diseases just as Western medicine (i.e. What disease? With what medicament? Cure how long? What effect does it achieve?). It solves the problem of no medicine for the repair of the bone and cartilage cells, and provides a model for quantitatively and selectively cure human major organic diseases by applying a fixed prescription of a Chinese herbal compound, which has proved that the application of original thinking of traditional Chinese medicine, combined with modern technology, can create many original achievements. At the same time, it also provides strong support for the industrialization and internationalization of traditional Chinese medicine. This is a great contribution of Chinese medicine to the world.
General secretary Xi Jinping pointed out, we should follow the law of development of traditional Chinese medicine, with the same emphasis on traditional Chinese medicine and Western medicine, and promote traditional Chinese medicine to the world. Wang Lulin said, we are willing to strengthen cooperation with people of insight and companies all over the world, jointly do a good job in the big health industry, promote the development and research of traditional Chinese medicine to the world, realize industrialization and internationalization, and to contribute China’s wisdom and strength to human life and health, and welcome the man of insight and companies to ally the cooperation, and benefits the world.
According to statistics, one-third of people worldwide will be endangered by bone diseases. According to the statistics of the National Health and Family Planning Commission of the People's Republic of China, the total population of China is about 1.4 billion, more than 120 million people suffer from osteoarthritis, more than 120 million people suffer from cervical spondylosis, more than 200 million people suffer from lumbar spondylosis, more than 90 million people suffer from osteoporosis in 2020, and a total of about 530 million people suffer from bone diseases, accounting for 36.4% of the total population. In 2015, CHin Med J (Engl) and Orthopaedic Surgery journals reported that the incidence of single osteonecrosis of the femoral head in China was about 0.725, totaling about 10.15 million people with the disease. The incidence of bone diseases in over 7 billion people in the world may be similar to that in China. If the company does a better business, the revenues may reach tens of billions or thousands of RMB by only one disease of single osteonecrosis.
Therefore, the alliance and cooperation of the man of insight and companies, can bring great social and economic benefits to the enterprises, even increase their stock market price by several times. It can also improve social popularity and influence, become the leader of green medical care in the world, relieve pain for the mankind, reduce disability, benefit mankind and benefit society.
